TABLE 2.
Comparison of total macrolide use among Canada and the reporting European Surveillance of Antimicrobial Resistance Network countries according to defined daily doses (DDDs) per 1000 inhabitant-days (DID), prescriptions per 1000 inhabitant-days (PrIDs) and DDD per prescription (Rx) measures in 2009
| Country/province |
DID
|
PrID
|
DDD per Rx
|
|||
|---|---|---|---|---|---|---|
| Value | Rank | Value | Rank | Value | Rank | |
| Alberta | 4.38 | 35 | 0.42 | 12 | . | . |
| Austria | 3.93 | 31 | 0.60 | 25 | 6.51 | 9 |
| Belgium | 2.96 | 17 | 0.39 | 10 | 7.55 | 14 |
| British | 3.74 | 25 | 0.34 | 7 | . | . |
| Columbia | ||||||
| Bulgaria | 3.20 | 19 | 0.56 | 23 | 5.67 | 5 |
| Canada | . | . | . | . | 9.88 | 17 |
| Croatia | 3.24 | 20 | 0.59 | 24 | 5.52 | 3 |
| Cyprus | 3.98 | 32 | NR | NR | NR | NR |
| Czech Republic† | 3.66 | 23 | 0.49 | 19 | 7.40 | 13 |
| Denmark | 2.25 | 13 | 0.28 | 4 | 8.00 | 16 |
| Estonia | 2.09 | 12 | 0.33 | 5 | 6.41 | 8 |
| Finland | 1.46 | 4 | 0.24 | 3 | 5.98 | 7 |
| France | 4.15 | 33 | NR | NR | NR | NR |
| Germany | 2.51 | 15 | NR | NR | NR | NR |
| Greece | 11.54 | 42 | 1.09 | 26 | 10.60 | 18 |
| Hungary | 3.00 | 18 | NR | NR | NR | NR |
| Iceland | 1.15 | 3 | NR | NR | NR | NR |
| Ireland† | 3.79 | 26 | 0.49 | 18 | 7.73 | 15 |
| Israel | 1.90 | 9 | NR | NR | NR | NR |
| Italy* | 5.33 | 39 | 1.68 | 27 | 3.18 | 1 |
| Latvia | 0.87 | 2 | NR | NR | NR | NR |
| Lithuania | 1.93 | 11 | 0.33 | 6 | 5.86 | 6 |
| Luxembourg | 3.87 | 28 | NR | NR | NR | NR |
| Malta | 3.89 | 30 | NR | NR | NR | NR |
| Manitoba | 3.63 | 21 | 0.43 | 13 | . | . |
| New Brunswick | 4.62 | 37 | 0.46 | 16 | . | . |
| Newfoundland and Labrador | 6.53 | 41 | 0.55 | 22 | . | . |
| Norway | 1.68 | 6 | NR | NR | NR | NR |
| Nova Scotia | 4.35 | 34 | 0.44 | 14 | . | . |
| Ontario | 4.51 | 36 | 0.48 | 17 | . | . |
| Prince Edward | 4.95 | 38 | 0.52 | 20 | . | . |
| Island | ||||||
| Poland | 3.88 | 29 | NR | NR | NR | NR |
| Portugal | 3.83 | 27 | 0.53 | 21 | 7.17 | 11 |
| Quebec | 3.74 | 24 | 0.36 | 8 | . | . |
| Romania | 1.84 | 8 | NR | NR | NR | NR |
| Russian Federation | 1.72 | 7 | 0.38 | 9 | 4.51 | 2 |
| Saskatchewan | 3.65 | 22 | 0.44 | 15 | . | . |
| Slovakia | 6.09 | 40 | NR | NR | NR | NR |
| Slovenia | 2.33 | 14 | 0.41 | 11 | 5.63 | 4 |
| Spain | 1.90 | 10 | NR | NR | NR | NR |
| Sweden | 0.63 | 1 | 0.09 | 1 | 7.21 | 12 |
| The Netherlands | 1.46 | 5 | 0.22 | 2 | 6.55 | 10 |
| United Kingdom | 2.51 | 16 | NR | NR | NR | NR |
Lowest use ranking = 1.
*
2008 values;
†
2007 values. NR Not reported